After completing this activity, pharmacists should be able to:
- Describe eczema triggers and their avoidance strategies
- Describe topical non-steroids for eczema treatment
- Describe the place for the new topical PDE4 inhibitor crisaborole in eczema therapy
The 2016 Competency Standards addressed by this activity include: 1.5, 2.2, 3.1, 3.2, 3.3, 3.5
Accreditation number: A2004RP1 Accreditation expires: 31/03/2022
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.